Step 2/3
Implantable Cardioverter Defibrillators
Last updated on August 14, 2023
Related Content
October 23, 2023 — Medtronic plc, a global leader in healthcare technology, has received U.S. Food and Drug ...
October 23, 2023 
August 28, 2023 — Is the routine implantation of an implantable cardioverter defibrillator (ICD) in myocardial ...
August 28, 2023 
August 28, 2023 — Upgrade to cardiac resynchronization therapy with a defibrillator (CRT-D) reduces morbidity and ...
August 28, 2023 
July 18, 2023 — The U.S. Food and Drug Administration (FDA) has issued a Class I recall on the Medtronic ICDs and CRT-Ds ...
July 18, 2023 
March 7, 2023 — Ninety-five percent of athletes with a diagnosed and treated genetic heart disease experienced no ...
March 07, 2023 
Medtronic Receives CE Mark for Extravascular Defibrillator System That Treats Abnormal Heart Rhythms
February 17, 2023 — Medtronic plc has received CE (Conformité Européenne) Mark for the Aurora EV-ICD MRI SureScan ...
February 17, 2023 
Medtronic Extravascular ICD meets global pivotal clinical trial’s safety and effectiveness endpoints
August 29, 2022 — Medtronic plc announced that its investigational EV ICD System – a first-of-its-kind defibrillator ...
August 29, 2022 
August 19, 2022 — According to a release just issued by the U.S. Food and Drug Administration (FDA), Medtronic is ...
August 19, 2022 
August 18, 2022 — A first-in-human multicenter trial involving Mayo Clinic used a new ablation technique for patients ...
August 18, 2022 
July 21, 2022 — The global automated external defibrillators market size was valued at USD 717 million in 2021. It is ...
July 22, 2022 © Copyright Wainscot Media. All Rights Reserved.
Subscribe Now